Home > NRC Library > ADAMS Public Documents

License 35-26817-01 for Sepratech Corp,authorizing use of ref licensed matls in R&D & in vitro biomedical test by,or under supervision of,AR Dorn or others as specified in 860422 ltr.

Accession Number: ML20203C497

Date Released: Tuesday, October 29, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20203C520 - Forwards License 35-26817-01. (2 page(s), 5/2/1986)
• ML20203C543 - Responds to 860401 request for addl info re application for license.Licensee intends to conduct lab work using available preformulated biomedical in vitro radiochemicals.Supporting documentation encl. (28 page(s), 4/22/1986)
• ML20203C557 - Requests addl info needed to complete review of application for license,including detailed description of planned calibr procedures for radiation survey & monitoring instruments. Reply requested within 30 days. (6 page(s), 4/1/1986)
• ML20203C564 - Forwards application for license,authorizing in vitro biomedical tests.Radiation program prepared by P Skierkowski.P Skierkowski also conducting initial training in lab safety,survey methods & other actions. (1 page(s), 1/20/1986)
• ML20203C581 - Application for license,authorizing use of organic & inorganic forms of listed radiochemicals for in vitro biomedical tests,including immune function testing of blood samples & radioimmunoassays.Fee paid. (12 page(s), 1/21/1986)